Related Experiment Video
Updated: Aug 9, 2026
07:48
Three-Dimensional In Vitro Biomimetic Model of Neuroblastoma Using Collagen-Based Scaffolds
Published on: July 9, 2021
Opioids regulate cGMP formation in cloned neuroblastoma cells
1Laboratory of Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, D.C. 20032.
Summary
Opioid agonists increase cyclic GMP (cGMP) in neuroblastoma cells, correlating with opioid receptor binding. Short-term desensitization of this response occurs without reducing opioid receptor numbers.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Opioid agonists are known to interact with cellular signaling pathways.
- Cyclic guanosine monophosphate (cGMP) is a key second messenger in various cellular processes.
- Understanding opioid receptor signaling is crucial for developing targeted therapeutics.
Purpose of the Study:
- To investigate the effect of opioid agonists on cGMP accumulation in N4TG1 neuroblastoma cells.
- To characterize the desensitization process of opioid-induced cGMP signaling.
- To determine the relationship between opioid binding and cGMP response desensitization.
Main Methods:
- Measurement of intracellular cGMP levels in response to various opioid agonists and antagonists.
- Radioligand binding assays using [(3)H]etorphine ([(3)H]ETP) to assess opioid receptor occupancy and affinity.
- Induction of receptor desensitization through prolonged exposure to opioid agonists.
- Analysis of dose-response relationships and kinetic parameters (EC50, Ka, t(1/2)).
Main Results:
- Opioid agonists rapidly increased cGMP levels in a dose-dependent manner, correlating with their binding affinity.
- Narcotic antagonists like naloxone blocked agonist-induced cGMP accumulation and desensitization.
- Short-term incubation with opioid agonists led to desensitization of cGMP response, characterized by decreased maximal response and increased EC50.
- Desensitized cells showed no immediate loss of high-affinity [(3)H]ETP binding sites, but prolonged exposure reduced maximal binding.
Conclusions:
- Opioid agonists stimulate cGMP production in N4TG1 cells via specific receptor interactions.
- A rapid, reversible desensitization of cGMP accumulation occurs, independent of immediate changes in receptor number.
- This desensitization mechanism may involve post-binding events rather than a reduction in available opioid receptors.
